Thermo and NanoPin Announce Collaboration
Thermo Fisher Scientific has announced a collaboration with NanoPin Technologies, Inc. to improve blood-based infectious disease detection technology through the development of highly sensitive LC–MS‑based workflows.
Thermo Fisher Scientific (Waltham, Massachusetts, USA) has announced a collaboration with NanoPin Technologies, Inc. (New Orleans, Louisiana, USA) to improve blood-based infectious disease detection technology through the development of highly sensitive liquid chromatography–mass spectrometry (LC–MS)âbased workflows.
The companies will combine Thermo Fisher’s LC–MS technology with NanoPin’s diagnostic platform to detect disease-related antigens directly from patient blood samples, which will lead to the development of sensitive clinical assays for infectious disease. The overall aim is to reduce diagnosis times and improve the determination of infection stage, as well as monitor patient response to prescribed treatments.
For more information please visit: www.thermofisher.com
Sustainability and Environmental Awareness in the World of Separation Science
April 22nd 2024In this written interview with Dwight Stoll, LCGC Columnist and Professor of Chemistry at Gustavus Adolphus College in St. Peter, Minnesota to address the pressing issues of sustainability and environmental awareness in separation science.
